Management of acute heart failure exacerbation

Critical Care Clinics

Volumn 17, Issue 2, 2001, Pages 321-335

  Kao, Walter ^a,b   Pavlovic Surjancev, Biljana ^a  

^a Rush Heart Failure and Cardiac Transplant Program   (United States)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; NONSTEROID ANTIINFLAMMATORY AGENT;

ACUTE HEART FAILURE; ARTIFICIAL HEART; ASSISTED CIRCULATION; ECHOCARDIOGRAPHY; HEART INDEX; HEART OUTPUT; HEART TRANSPLANTATION; MORTALITY; PRIORITY JOURNAL; REVIEW;

EID: 0034962656     PISSN: 07490704     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0749-0704(05)70170-6     Document Type: Article

References (49)

1. Risk stratification for coronary bypass surgery in patients with left ventricular dysfunction: Analysis of the Coronary Artery Bypass Grafting Patch Trial database
2. Delay in revascularization is associated with increased mortality rate in patients with severe left ventricular dysfunction and viable myocardium on fluorine 18-fluorodeoxyglucose positron emission tomography imaging
3. Coronary surgery on the beating heart under extracorporeal ciculation in high-risk patients. An acceptable compromise
4. Comparison of intravenous milrinone and dobutamine for congestive heart failure secondary to either ischemic or dilated cardiomyopathy
5. Intermediate term outcome of mitral reconstruction in cardiomyopathy
6. Comparative effects of therapy with captopril and digoxin in patients with mild to moderate heart failure
7. Effect of propranolol after acute myocardial infarction in patients with congestive heart failure
8. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): A randomized trial
9. Prognostic significance of serial changes in left ventricular ejection fraction in patients with congestive heart failure
10. A dose-dependent increase in mortality with vesnarinone among patients with severe heart failure
11. Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure
12. The effectiveness of right heart catheterization in the initial care of critically ill patients
13. Effects of enalapril on mortality in severe congestive heart failure: Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS)
14. Primary myocardial revascularization: Trends in surgical mortality
15. A comparison of two antimicrobial-impregnated central venous catheters
16. Ambulatory intermittent 6-month low-dose dobutamine infusion in severe heart failure: DICE multicenter trial
17. Outcome of left ventricular aneurysmectomy with patch repair in patients with severely depressed pump function
18. Intermittent dobutamine in ambulatory outpatients with chronic cardiac failure
19. Diuretic efficacy of high dose furosemide in severe heart failure: Bolus injection versus continuous infusion
20. Differential effects of milrinone and dobutamine on right ventricular preload, afterload and systolic performance in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy
21. Inotropic agents for chronic congestive heart failure: Medical miracles or misguided medicinals?
22. Effects of vesnarinone or morbidity and mortality in patients with heart failure
23. Indications for fibrinolytic therapy in suspected acute myocardial infarction: Collaborative overview of early mortality and major morbidity results from all randomized trials of more than 1000 patients
24. Multicenter trial of dynamic cardiomyoplasty for chronic heart failure
25. Changes in mortality from heart failure-United States, 1980- 1995
26. Reevaluation of the role of continuous inotropic support in patients with advanced heart failure
27. Early revascularization in acute myocardial infarction complicated by cardiogenic shock
28. The Registry of the International Society for Heart and Lung Transplantation: 17th Official Report
29. Initial clinical experience with intra-aortic balloon pumping in cardiogenic shock
30. The intra-aortic balloon pump: An analysis of five years' experience
31. Radiographic pulmonary congestion in endstage congestive heart failure
32. Prevention of central venous catheter-related bloodstream infection by use of an antiseptic-impregnated catheter
33. Bedside catheterization of the pulmonary artery: Risks compared with benefits
34. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomized Intervention Trial in Congestive Heart Failure (MERIT-HF)
35. Outpatient dobutamine for refractory congestive heart failure: Advantages, techniques and results
36. Present use of bedside right heart catheterization in patients with cardiac disease
37. Economic impact of heart failure in the United States: Time for a different approach
38. Insights from three-dimensional echocardiography into the mechanism of functional mitral regurgitation: Direct in vivo demonstration of altered leaflet tethering geometry
39. Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF) trial results
40. Effect of oral milrinone on mortality in severe chronic heart failure
41. Epidemiology, pathophysiology and etiology of congestive heart failure in older adults
42. The mechanism of decrease in dynamic mitral regurgitation during heart failure treatment: Importance of reduction in the regurgitant orifice size
43. The Rematch trial: Rationale, design, and end points. Randomized evaluation of mechanical assistance for the treatment of congestive heart failure
44. Effect of enalapril on survival in patients with reduced left ventricular ejection fraction and congestive heart failure
45. Results of partial left ventriculectomy for dilated cardiomyopathy
46. Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction: A quantitative review
47. Hydralazine and isosorbide dinitrate combination improves exercise tolerance in heart failure: Results from V- HeFT I and V-HeFT II